Funds totalling RM25 million* ($US6.8 million) per annum have been set aside by the Malaysian government News item 09 February 2013 Pages: 2 - 2
The UK Drug and Therapeutics Bulletin (DTB),* has published a warning regarding the development and marketing of new forms of established drugs News item 09 February 2013 Pages: 4 - 4
Terlipressin stems cash flow in bleeding oesophageal varices Clinical study 09 February 2013 Pages: 5 - 5
Inappropriate drug intake is not uncommon among elderly Lebanese outpatients, Non-clinical study 09 February 2013 Pages: 5 - 5
Vasectomy reversal is more cost effective than immediate ART* for treating male infertility resulting from vasectomy obstruction Clinical study 09 February 2013 Pages: 5 - 5
OTC analgesics are overused by a “clinically significant” proportion of patients Clinical study 09 February 2013 Pages: 6 - 6
According to a US cost analysis,* inpatient candidaemia treatment is “extremely costly” Clinical study 09 February 2013 Pages: 6 - 6
A defined set of preoperative characteristics is independently associated with adverse health outcomes in patients undergoing radical cystectomy Clinical study 09 February 2013 Pages: 6 - 6
Hospitalisations for systemic lupus erythematosus (SLE) are expensive Clinical study 09 February 2013 Pages: 7 - 7
Laparoscopy followed by expectant management is the most cost-effective strategy for managing unexplained infertility in young couples, Clinical study 09 February 2013 Pages: 7 - 7
Universal bone densitometry plus bisphosphonate therapy is worth it for men aged > 65 years with a prior fracture since age 50 years, Clinical study 09 February 2013 Pages: 7 - 7
Janssen Pharmaceutica has announced that its risperidone long-acting injection has been shown to decrease hospitalisation rates and medical costs. Media release 09 February 2013 Pages: 7 - 7
Insurance status/ethnicity affects utilisation of high-volume hospitals News item 09 February 2013 Pages: 8 - 8
The introduction of universal childhood vaccination with the pneumococcal 7-valent CRM197 vaccine conjugate Clinical study 09 February 2013 Pages: 8 - 8
Sorafenib therapy does not compromise the QOL of patients with renal cancer, Clinical study 09 February 2013 Pages: 9 - 9
Intranasal azelastine vs oral cetirizine for seasonal rhinitis Clinical study 09 February 2013 Pages: 9 - 9
Diabetes treatment targets fall short despite guidelines Clinical study 09 February 2013 Pages: 9 - 9
Reference pricing and formularies rejected by UK government News item 09 February 2013 Pages: 10 - 10
Financial agreements have been signed between the Azerbaijani government and several organisations to aid in reforming the national healthcare system News item 09 February 2013 Pages: 10 - 10
UK NICE issues guidelines for breast cancer and urinary incontinence... News item 09 February 2013 Pages: 10 - 10
Merck and Co. has announced that the US Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices Media release 09 February 2013 Pages: 10 - 10
Pharmac, New Zealand's drug funding agency, has announced a new package of treatments Media release 09 February 2013 Pages: 10 - 10
The French Senior health authority is set to advise the government to remove reimbursement for 145 drug products News item 09 February 2013 Pages: 11 - 11
The pharmaceutical market in Romania was worth euro1.13 billion in the 12 months ending March 2006, News item 09 February 2013 Pages: 11 - 11
AstraZeneca has announced that it will provide new assistance for those struggling to pay for their medicines. Media release 09 February 2013 Pages: 11 - 11